Baker Brothers Advisors - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 47 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$38,000
-75.9%
139,105
-69.2%
0.00%
-100.0%
Q2 2022$158,000
-48.5%
451,4780.0%0.00%
-50.0%
Q1 2022$307,000
-70.6%
451,4780.0%0.00%
-60.0%
Q4 2021$1,043,000
-49.6%
451,4780.0%0.01%
-44.4%
Q3 2021$2,068,000
+3.1%
451,4780.0%0.01%0.0%
Q2 2021$2,005,000
-39.0%
451,4780.0%0.01%
-35.7%
Q1 2021$3,287,000
-4.6%
451,4780.0%0.01%
+7.7%
Q4 2020$3,445,000451,4780.01%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 500,000$2,470,0000.65%
Orbimed Advisors 6,466,783$31,946,0000.54%
SAMLYN CAPITAL, LLC 798,566$3,945,0000.10%
ADAGE CAPITAL PARTNERS GP, L.L.C. 915,355$4,522,0000.01%
IHT Wealth Management, LLC 11,660$58,0000.01%
FIDUCIARY TRUST CO 37,998$188,0000.01%
FRANKLIN RESOURCES INC 700,000$3,458,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 13,700$68,0000.00%
Tower Research Capital LLC (TRC) 2,249$11,0000.00%
MANCHESTER FINANCIAL INC 200$1,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders